Piper Jaffray Starts Cytokinetics (CYTK) at Overweight
Tweet Send to a FriendGet Alerts CYTK Hot Sheet
Price: $1.16 -1.69%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade CYTK Now!
Piper Jaffray initiates coverage on Cytokinetics (NASDAQ: CYTK) with a Overweight. PT $4.00.
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $0.67 yesterday, with a 52 week range of $0.57-$1.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $0.67 yesterday, with a 52 week range of $0.57-$1.29.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Janney Capital Boosts PT on Gap (GPS) Post Q1
- Topeka Capital Starts InvenSense (INVN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
